Inflammation Modulation Unlike NSAIDs, which blunt inflammation indiscriminately, BPC-157 appears to reduce pro-inflammatory signalling while preserving the inflammatory response necessary for healing, a pattern summarized across the preclinical literature in a 2025 narrative review of BPC-157 for musculoskeletal healing McGuire et al
Mutations in these genes can lead to high levels of homocysteine, linked to heart disease and other health issues
This makes it a potential game-changer for conditions like Alzheimers disease, dementia, Parkinsons, and traumatic brain injury, as well as a candidate for those seeking long-term cognitive enhancement
Keep in mind that the medication should be compatible with benzyl alcohol, the bacteriostatic preservative present in bacteriostatic water
The worry around cancer mostly stems from BPC-157s ability to support angiogenesis, or the growth of new blood vessels
Panther EJ, Zelmanovich R, Hernandez J, Dioso ER, Foster D, Lucke-Wold B